|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.80 CHF | +1.36% |
|
+0.17% | +15.69% |
| 08:40pm | US FDA approves Vera's kidney disease drug | RE |
| 12:31pm | NOVARTIS AG : Deutsche Bank reiterates its Buy rating | ZD |
| Market Cap | 284B 248B 229B 212B 403B 26,943B 409B 2,745B 1,068B 13,297B 1,066B 1,043B 45,961B | P/E 2026 * |
21.6x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 316B 276B 255B 236B 448B 29,983B 456B 3,055B 1,188B 14,797B 1,186B 1,160B 51,146B | EV / Sales 2026 * |
5.56x | EV / Sales 2027 * | 5.18x |
| Free-Float |
91.66% | Yield 2026 * |
2.84% | Yield 2027 * | 2.93% |
Last Transcript: Novartis AG
| 1 day | +1.44% | ||
| 1 week | +0.17% | ||
| Current month | +0.17% | ||
| 1 month | +8.06% | ||
| 3 months | +5.84% | ||
| 6 months | +11.62% | ||
| Current year | +15.69% |
| 1 week | 123.96 |  | 128.92 |
| 1 month | 116.42 | | 128.92 |
| Current year | 107.68 | | 131 |
| 1 year | 91.2 | | 131 |
| 3 years | 81.1 | | 131 |
| 5 years | 72.84 | | 131 |
| 10 years | 65.09 | | 131 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-18 | Sell | -5,200 | 0.0003% | |||
| 05-04 | Sell | 6,800 | 0.0003% | |||
| 02-17 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +2.56% | +2.49% | +59.05% | +171.91% | 1,070B | |
| +2.51% | +4.37% | +70.72% | +66.46% | 624B | |
| +0.04% | +1.29% | +35.85% | +88.11% | 450B | |
| +2.14% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.87% | +1.87% | +40.58% | +42.08% | 292B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.05% | +1.39% | +25.33% | +67.91% | 198B | |
| +3.81% | +6.21% | +20.04% | +80.30% | 161B | |
| +0.95% | -0.44% | -5.01% | -32.52% | 135B | |
| Average | +1.74% | +0.61% | +27.83% | +51.71% | 375.95B | |
| Weighted average by Cap. | +1.90% | +0.58% | +41.18% | +83.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.87B 49.76B 45.86B 42.51B 80.69B 5,397B 82B 550B 214B 2,664B 213B 209B 9,206B | 60.31B 52.78B 48.64B 45.08B 85.58B 5,724B 86.96B 583B 227B 2,825B 226B 222B 9,764B |
| Net income | 14.1B 12.34B 11.37B 10.54B 20.01B 1,339B 20.34B 136B 53.04B 661B 52.95B 51.8B 2,283B | 15.65B 13.69B 12.62B 11.7B 22.2B 1,485B 22.56B 151B 58.85B 733B 58.75B 57.47B 2,533B |
| Net Debt | 32.03B 28.03B 25.83B 23.94B 45.45B 3,040B 46.18B 310B 120B 1,500B 120B 118B 5,185B | 28.54B 24.97B 23.01B 21.33B 40.5B 2,708B 41.15B 276B 107B 1,337B 107B 105B 4,620B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | CHF 126.80 | +1.36% | 2,306,045 |
| 06/07/26 | CHF 125.10 | -2.20% | 2,283,429 |
| 03/07/26 | CHF 127.92 | -0.08% | 1,776,406 |
| 02/07/26 | CHF 128.02 | +2.42% | 2,503,792 |
| 01/07/26 | CHF 125.00 | -1.25% | 2,796,920 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
